Literature DB >> 21816821

Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Lieh Yoon Low1, Chen Yang, Marta Perego, Andrei Osterman, Robert Liddington.   

Abstract

The recombinant lysins of lytic phages, when applied externally to Gram-positive bacteria, can be efficient bactericidal agents, typically retaining high specificity. Their development as novel antibacterial agents offers many potential advantages over conventional antibiotics. Protein engineering could exploit this potential further by generating novel lysins fit for distinct target populations and environments. However, access to the peptidoglycan layer is controlled by a variety of secondary cell wall polymers, chemical modifications, and (in some cases) S-layers and capsules. Classical lysins require a cell wall-binding domain (CBD) that targets the catalytic domain to the peptidoglycan layer via binding to a secondary cell wall polymer component. The cell walls of Gram-positive bacteria generally have a negative charge, and we noticed a correlation between (positive) charge on the catalytic domain and bacteriolytic activity in the absence of the CBD (nonclassical behavior). We investigated a physical basis for this correlation by comparing the structures and activities of pairs of lysins where the lytic activity of one of each pair was CBD-independent. We found that by engineering a reversal of sign of the net charge of the catalytic domain, we could either eliminate or create CBD dependence. We also provide evidence that the S-layer of Bacillus anthracis acts as a molecular sieve that is chiefly size-dependent, favoring catalytic domains over full-length lysins. Our work suggests a number of facile approaches for fine-tuning lysin activity, either to enhance or reduce specificity/host range and/or bactericidal potential, as required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816821      PMCID: PMC3190764          DOI: 10.1074/jbc.M111.244160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  90 in total

1.  Identification of four families of peptidoglycan lytic transglycosylases.

Authors:  N T Blackburn; A J Clarke
Journal:  J Mol Evol       Date:  2001-01       Impact factor: 2.395

2.  Phages will out: strategies of host cell lysis.

Authors:  I Young; I Wang; W D Roof
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

3.  The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall.

Authors:  Stephen A Beers; Andrew G Buckland; Rao S Koduri; Wonhwa Cho; Michael H Gelb; David C Wilton
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

Review 4.  How do bacteria resist human antimicrobial peptides?

Authors:  Andreas Peschel
Journal:  Trends Microbiol       Date:  2002-04       Impact factor: 17.079

5.  Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth.

Authors:  C Liu; E Gelius; G Liu; H Steiner; R Dziarski
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

6.  Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Authors:  J M Loeffler; D Nelson; V A Fischetti
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

7.  Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.

Authors:  A K Foreman-Wykert; Y Weinrauch; P Elsbach; J Weiss
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 8.  The antibacterial properties of secreted phospholipases A(2).

Authors:  A G Buckland; D C Wilton
Journal:  Biochim Biophys Acta       Date:  2000-10-31

9.  Bacterial cell membrane hydrolysis by secreted phospholipases A(2): a major physiological role of human group IIa sPLA(2) involving both bacterial cell wall penetration and interfacial catalysis.

Authors:  A G Buckland; E L Heeley; D C Wilton
Journal:  Biochim Biophys Acta       Date:  2000-04-12

10.  C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates.

Authors:  Martin J Loessner; Karl Kramer; Frank Ebel; Siegfried Scherer
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

View more
  47 in total

1.  Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity.

Authors:  Hang Yang; Dehua Luo; Irina Etobayeva; Xiaohong Li; Yujing Gong; Shujuan Wang; Qiong Li; Poshi Xu; Wen Yin; Jin He; Daniel C Nelson; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 2.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

3.  Electrostatic-Mediated Affinity Tuning of Lysostaphin Accelerates Bacterial Lysis Kinetics and Enhances In Vivo Efficacy.

Authors:  Hongliang Zhao; Susan Eszterhas; Jacob Furlon; Hao Cheng; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

4.  A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.

Authors:  Rolf Lood; Assaf Raz; Henrik Molina; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

5.  Characterization of the N-Terminal Catalytic Domain of Lytµ1/6, an Endolysin from Streptomyces aureofaciens Phage µ1/6.

Authors:  Jarmila Farkašovská; Andrej Godány
Journal:  Curr Microbiol       Date:  2016-07-23       Impact factor: 2.188

6.  Using a Novel Lysin To Help Control Clostridium difficile Infections.

Authors:  Qiong Wang; Chad W Euler; Aurelia Delaune; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

7.  Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'.

Authors:  Mathias Schmelcher; Olga Korobova; Nina Schischkova; Natalia Kiseleva; Paul Kopylov; Sergey Pryamchuk; David M Donovan; Igor Abaev
Journal:  J Biotechnol       Date:  2012-09-28       Impact factor: 3.307

Review 8.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

9.  Unprotonated Short-Chain Alkylamines Inhibit Staphylolytic Activity of Lysostaphin in a Wall Teichoic Acid-Dependent Manner.

Authors:  Xia Wu; Seok Joon Kwon; Domyoung Kim; Jian Zha; Mauricio Mora-Pale; Jonathan S Dordick
Journal:  Appl Environ Microbiol       Date:  2018-07-02       Impact factor: 4.792

10.  The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.

Authors:  Jhuma Ganguly; Lieh Y Low; Nazia Kamal; Elke Saile; L Scott Forsberg; Gerardo Gutierrez-Sanchez; Alex R Hoffmaster; Robert Liddington; Conrad P Quinn; Russell W Carlson; Elmar L Kannenberg
Journal:  Glycobiology       Date:  2013-03-14       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.